Juthi R, Sazed S, Mareboina M, Zaravinos A, Georgakopoulos-Soares I
Int J Mol Sci. 2025; 26(5).
PMID: 40076932
PMC: 11899893.
DOI: 10.3390/ijms26052311.
Kim M, Kong D, Kim N, Kim M, Kim H, Choi J
BMC Vet Res. 2025; 21(1):115.
PMID: 40011929
PMC: 11866708.
DOI: 10.1186/s12917-025-04554-w.
Salomao N, Araujo L, de Souza L, Luiza Young A, Basilio-de-Oliveira C, Basilio-de-Oliveira R
Front Microbiol. 2025; 16:1497354.
PMID: 39935638
PMC: 11811090.
DOI: 10.3389/fmicb.2025.1497354.
Srishti S, Pinky P, Taylor R, Guess J, Karlik N, Janjic J
Pharmaceutics. 2025; 16(12.
PMID: 39771467
PMC: 11678404.
DOI: 10.3390/pharmaceutics16121487.
Han S, Kang J, Choi Y, Yang D, Kim K, Boo H
In Vivo. 2024; 39(1):201-209.
PMID: 39740923
PMC: 11705120.
DOI: 10.21873/invivo.13818.
Keratinocytes - Amplifiers of Immune Responses in Systemic Lupus Erythematosus.
Klein B, Nguyen N, Moallemian R, Kahlenberg J
Curr Rheumatol Rep. 2024; 27(1):1.
PMID: 39570551
DOI: 10.1007/s11926-024-01168-3.
Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions.
Speeckaert R, Belpaire A, Lambert J, Speeckaert M, van Geel N
Immune Netw. 2024; 24(5):e33.
PMID: 39513029
PMC: 11538609.
DOI: 10.4110/in.2024.24.e33.
Curcumin-Loaded Nanocomposite Hydrogel Dressings for Promoting Infected Wound Healing and Tissue Regeneration.
Fu Z, Zou J, Zhong J, Zhan J, Zhang L, Xie X
Int J Nanomedicine. 2024; 19:10479-10496.
PMID: 39439502
PMC: 11495204.
DOI: 10.2147/IJN.S479330.
Cutaneous adaptive immunity and uraemia: a narrative review.
Zibandeh N, Li Z, Ogg G, Bottomley M
Front Immunol. 2024; 15:1464338.
PMID: 39399503
PMC: 11466824.
DOI: 10.3389/fimmu.2024.1464338.
Universal CAR 2.0 to overcome current limitations in CAR therapy.
Schlegel L, Werbrouck C, Boettcher M, Schlegel P
Front Immunol. 2024; 15:1383894.
PMID: 38962014
PMC: 11219820.
DOI: 10.3389/fimmu.2024.1383894.
An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.
Sadrolashrafi K, Guo L, Kikuchi R, Hao A, Yamamoto R, Tolson H
Cells. 2024; 13(7.
PMID: 38607026
PMC: 11011471.
DOI: 10.3390/cells13070587.
Radiation Dermatitis: Radiation-Induced Effects on the Structural and Immunological Barrier Function of the Epidermis.
Rube C, Freyter B, Tewary G, Roemer K, Hecht M, Rube C
Int J Mol Sci. 2024; 25(6).
PMID: 38542294
PMC: 10970573.
DOI: 10.3390/ijms25063320.
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets.
Clister T, Fey R, Garrison Z, Valenzuela C, Bar A, Leitenberger J
Cells. 2024; 13(3.
PMID: 38334658
PMC: 10854603.
DOI: 10.3390/cells13030266.
Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates.
Zabihi F, Cherri M, Guo X, Rancan F, Schumacher F, Mohammadifar E
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256910
PMC: 10821331.
DOI: 10.3390/ph17010077.
The Involvement of Cysteine-X-Cysteine Motif Chemokine Receptors in Skin Homeostasis and the Pathogenesis of Allergic Contact Dermatitis and Psoriasis.
Liu W
Int J Mol Sci. 2024; 25(2).
PMID: 38256077
PMC: 10815665.
DOI: 10.3390/ijms25021005.
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.
Croft M, Esfandiari E, Chong C, Hsu H, Kabashima K, Kricorian G
Am J Clin Dermatol. 2024; 25(3):447-461.
PMID: 38236520
PMC: 11070399.
DOI: 10.1007/s40257-023-00838-9.
Inhibition of T-cell activity in alopecia areata: recent developments and new directions.
Passeron T, King B, Seneschal J, Steinhoff M, Jabbari A, Ohyama M
Front Immunol. 2023; 14:1243556.
PMID: 38022501
PMC: 10657858.
DOI: 10.3389/fimmu.2023.1243556.
Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis.
Baritaki S, Zaravinos A
Cancers (Basel). 2023; 15(20).
PMID: 37894300
PMC: 10605344.
DOI: 10.3390/cancers15204932.
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma.
Chun K, Park Y, Hwang N, Yoon B, Kim J, Fang S
Sci Rep. 2023; 13(1):15023.
PMID: 37700026
PMC: 10497583.
DOI: 10.1038/s41598-023-42238-3.
Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus.
Lo H, Ip F
Skin Health Dis. 2023; 3(4):e228.
PMID: 37538322
PMC: 10395633.
DOI: 10.1002/ski2.228.